CAL
CRVO icon

Capital Advisors Ltd’s CervoMed CRVO Stock Holding History

Capital Advisors Ltd’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33
Closed – – 1410
2024
Q3 		$0 Buy
+33
New +$511 ﹤0.01% 1419

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital Advisors Ltd's CRVO Position: Q4 2024 in Review

Capital Advisors Ltd sold out of CervoMed (CRVO) in Q4 2024, closing a stake of 33 shares.

Capital Advisors Ltd first reported a position in CRVO in Q3 2024 and held it in 1 quarter. The position peaked at $0 in Q3 2024. 49 funds tracked by Wall St. Rank hold CRVO as of Q4 2024.

  • Capital Advisors Ltd reported no remaining CervoMed position as of Q4 2024 after selling out during the quarter.
  • Capital Advisors Ltd sold 33 CervoMed shares in Q4 2024.
  • Capital Advisors Ltd first reported a position in CervoMed in Q3 2024 and held it in 1 quarter.
  • Capital Advisors Ltd's CervoMed position peaked at $0 in Q3 2024.
  • 49 funds tracked by Wall St. Rank held CervoMed as of Q4 2024.

Based on Capital Advisors Ltd's 13F filing for Q4 2024, filed 4 Feb 2025.